Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: SCANDINAVIAN BIOPHARMA HOLDING AB
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-09-25 to 2023-09-25
Current total value of award: $12425875.78
Description: FURTHER DEVELOPMENT OF ETVAX, A VACCINE AGAINST ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC).